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SI 1
Materials and Methods 
 
Unless stated otherwise, reactions were performed at ambient temperature (23 °C) in 
flame-dried glassware under an argon atmosphere using dry, deoxygentated solvents 
(distilled or passed over a column of activated alumina). 1  Commercially available 
reagents were used as received. Reactions requiring external heat were modulated to the 
specified temperatures using an IKAmag temperature controller. Thin-layer 
chromatography (TLC) was performed using E. Merck silica gel 60 F254 pre-coated 
plates (250 nm) and visualized by UV fluorescence quenching, potassium permanganate, 
or p-anisaldehyde staining. Silicycle SiliaFlash P60 Academic Silica gel (particle size 40-
63 nm) was used for flash chromatography. Potassium (2-benzyloxy)ethyl-
trifluoroborate, 2  (S)-(CF3)-t-BuPHOX, 3  and tris(4,4’-
methoxydibenzylideneacetone)dipalladium(0) [Pd2(pmdba)3]4 were prepared by known 
methods. NBS was purchased from Sigma Aldrich, recrystallized from H2O, and stored 
in a –25 °C freezer. 2-tert-Butoxy-2-oxoethylzinc chloride (0.5 M in Et2O) was 
purchased from Rieke Metals and used within three days. Bis(cyclopentadienyl) 
zirconium chloride hydride was purchased from Strem Chemicals and stored at room 
temperature in a N2-filled glovebox. Hydroxylamine-O-sulfonic acid was purchased from 
Sigma Aldrich and stored at –30°C in the glovebox freezer. Triethylamine was distilled 
from calcium hydride immediately prior to use. MeOH was distilled from magnesium 
methoxide immediately prior to use. Purified water was obtained using a Barnstead 
NANOpure Infinity UV/UF system. 1H and 13C NMR spectra were recorded on a Varian 
Inova 500 (500 MHz and 126 MHz, respectively) and a Bruker AV III HD spectrometer 
equipped with a Prodigy liquid nitrogen temperature cryoprobe (400 MHz and 101 MHz, 
respectively) and are reported in terms of chemical shift relative to CHCl3 (δ 7.26 and 
77.16, respectively). Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm) (multiplicity, coupling constant (Hz), integration). Infrared (IR) spectra were 
recorded on a Perkin Elmer Paragon 1000 Spectrometer and are reported in frequency of 
absorption (cm-1). Analytical chiral SFC was performed with a Mettler SFC supercritical 
CO2 analytical chromatography system with Chiralpak AD-H column obtained from 
Daicel Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained 
from the Caltech Mass Spectral Facility using a JEOL JMS-600H High Resolution Mass 
Spectrometer in fast atom bombardment (FAB+) or electron ionization (EI+) mode, or 
from the Caltech Center for Catalysis and Chemical Synthesis using an Agilent 6200 
series TOF with an Agilent G1978A Multimode source in mixed (Multimode ESI/APCI) 
ionization mode. Optical rotations were measured on a Jasco P-2000 polarimeter using a 
100 mm path-length cell at 589 nm. 
 
List of Abbreviations:  
 
AtaPhos – (di-tert-butyl(4-dimethylaminophenyl)phosphine), TBME – tert-butyl methyl 
ether, ee – enantiomeric excess, LHMDS – lithium bis(trimethylsilyl)amide, NBS – N–
bromosuccinimide, SFC – supercritical fluid chromatography, TFA – trifluoroacetic acid, 
THF – tetrahydrofuran, TLC – thin-layer chromatography 
 
 
SI 2
Experimental Procedures 
 
 
 
9-hydroxy-8,9-dihydropyrido[1,2-a]indol-6(7H)-one (S2): To a solution of tricycle S15 
(5.92 g, 29.7 mmol, 1.00 equiv) in THF (300 mL) was added NaBH4 (1.24 g, 32.8 mmol, 
1.1 equiv) in two equal portions over 10 min at 0°C. The reaction mixture was allowed to 
warm to 23 °C over the course of 2 h at which point full consumption of starting material 
was observed by TLC analysis. The reaction was quenched by the addition of saturated 
aqueous NH4Cl (100 mL). The biphasic mixture was poured into water (100 mL) and 
extracted with EtOAc (3 x 100 mL). The combined organic layers were dried over 
Na2SO4, filtered, and stripped onto silica gel. Flash column chromatography (SiO2, 
40% EtOAc in hexanes to 60% EtOAc in hexanes eluent) afforded alcohol S2 (5.03 g, 
84% yield) as a tan amorphous solid: Rf = 0.45 (1:1 EtOAc:hexanes eluent); 1H NMR 
(500 MHz, CDCl3) δ 8.46 (dq, J = 8.2, 0.9 Hz, 1H), 7.53 (ddd, J = 7.7, 1.4, 0.8 Hz, 1H), 
7.35 (ddd, J = 8.4, 7.3, 1.3 Hz, 1H), 7.30–7.26 (m, 1H), 6.60 (t, J = 0.8 Hz, 1H), 5.12 (t, J 
= 4.5 Hz, 1H), 3.19–3.11 (m, 1H), 2.74 (dt, J = 17.5, 5.1 Hz, 1H), 2.28–2.22 (m, 2H), 
1.96 (br s, 1H); 13C NMR (126 MHz, CDCl3) δ 169.1, 139.8, 135.1, 129.2, 125.5, 124.3, 
120.8, 116.8, 106.7, 62.6, 29.8, 29.6; IR (Neat Film, NaCl) 3396, 3059, 2960, 2934, 
1704, 1597, 1473, 1453, 1372, 1358, 1321, 1178, 1086, 1052, 1022, 1006, 980, 942, 814, 
754 cm-1; HRMS (ESI/APCI) m/z calc’d for C12H12NO2 [M+H]+: 202.0863, found 
202.0862. 
 
 
 
8,9-dihydropyrido[1,2-a]indol-6(7H)-one (9): Two flasks were each charged with 
alcohol S2 (4.38 g, 21.8 mmol, 1.00 equiv), CH2Cl2 (220 mL), and Et3SiH (7.6 g, 65.4 
mmol, 3.0 equiv). Each flask was then cooled to 0 °C in an ice water bath. To each flask 
was then added TFA (14.9 g, 130.8 mmol, 6.0 equiv) over 15 min at 0°C. The solution 
turned to dark purple, and was allowed to warm to 23 °C over the course of 2 h, then 
stirred at 23 °C for an additional 2 h. At this point, full consumption of starting material 
was observed by TLC analysis. The reaction was quenched by the careful addition of 
saturated aqueous NaHCO3 at 0 °C until evolution of gas ceased. The two reaction 
mixtures were combined in a separatory funnel, and extracted with CH2Cl2 (3 x 500 mL). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure. Flash column chromatography (SiO2, 20% Et2O in hexanes to 35% 
Et2O in hexanes eluent) afforded heteroarene 9 (5.0 g, 61% yield) as a white solid: Rf = 
0.25 (3:7 Et2O:hexanes eluent); physical and spectroscopic data were consistent with 
those reported in the literature.6 
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10-bromo-8,9-dihydropyrido[1,2-a]indol-6(7H)-one (10): To a solution of heteroarene 
9 (910 mg, 4.91 mmol, 1.00 equiv) in CH2Cl2 (20 mL) was charged NBS (900 mg, 5.05 
mmol, 1.02 equiv) in three equal portions over 15 min at 0°C. After 10 min, the cooling 
bath was removed and the reaction mixture was allowed to warm to 23 °C. Full 
consumption of starting material was complete within 20 minutes, as observed by TLC 
analysis. The crude reaction mixture was stripped onto silica gel and purified by flash 
column chromatography (SiO2, 25% hexanes in CH2Cl2 eluent) to afford heteroaryl 
bromide 10 (1.24 g, 95% yield) as a white amorphous solid: Rf = 0.45 (3:1 
CH2Cl2:hexanes eluent); 1H NMR (500 MHz, CDCl3) δ 8.46–8.42 (m, 1H), 7.49–7.44 
(m, 1H), 7.38–7.31 (m, 2H), 2.99 (dd, J = 6.9, 5.8 Hz, 2H), 2.84–2.80 (m, 2H), 2.19–2.10 
(m, 2H); 13C NMR (126 MHz, CDCl3) δ 168.9, 135.4, 134.0, 128.9, 125.5, 124.6, 118.5, 
116.5, 96.7, 34.4, 22.8, 20.9; IR (Neat Film, NaCl) 3405, 3052, 2959, 2878, 2837, 1907, 
1788, 1706, 1593, 1446, 1343, 1258, 1209, 1170, 1142, 1087, 1021, 982, 928, 908, 836, 
799, 746, 650, 618 cm-1; HRMS (FAB+) m/z calc’d for C12H10NOBr [M]+: 262.9940, 
found 262.9936. 
 
 
 
10-(2-(benzyloxy)ethyl)-8,9-dihydropyrido[1,2-a]indol-6(7H)-one (12): A 15 mL 
round bottom flask equipped with a magnetic stirring bar and a rubber septum was 
charged with heteroaryl bromide 10 (200 mg, 0.757 mmol, 1.0 equiv), potassium (2-
benzyloxy)ethyltrifluoroborate (11) (200 mg, 0.826 mmol, 1.1 equiv), PdCl2(Ataphos)2 
(16 mg, 22.5 µmol, 0.03 equiv), and Cs2CO3 (740 mg, 2.27 mmol, 3.0 equiv). The flask 
was evacuated and backfilled with argon three times. Toluene (3.1 mL) and degassed 
water (0.7 mL) were added via syringe, and the flask was placed into a preheated 80 °C 
oil bath with stirring. After stirring for 2 h, the biphasic reaction mixture was cooled to 23 
°C, poured into water (15 mL) and extracted with EtOAc (3 x 30 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure. 
Flash column chromatography (25% Et2O in hexanes) afforded heteroarene 12 (207 mg, 
86% yield) as a light yellow oil: Rf = 0.3 (3:2 hexanes:Et2O eluent); physical and 
spectroscopic data were consistent with those reported in the literature.7 
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allyl 10-(2-(benzyloxy)ethyl)-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-
carboxylate (S3): A flame-dried round bottom flask was charged with LHMDS (282 mg, 
1.69 mmol, 2.0 equiv) and a magnetic stirring bar in a N2-filled glove box. The flask was 
sealed, removed from the glovebox, fitted with an argon line, and suspended in a dry 
ice/acetone bath. THF (4.5 mL) was added slowly to the flask and allowed to stir until the 
LHMDS had been completely dissolved. A solution of heteroarene 12 (270 mg, 0.845 
mmol, 1.0 equiv) in THF (1.1 mL) was added dropwise, and the reaction was allowed to 
stir for 30 min at –78 °C. Allyl cyanoformate (112 mg, 1.01 mmol, 1.2 equiv) was then 
added dropwise, and the reaction was allowed to warm slowly to 0 °C over 4 h. Once the 
cooling bath temperature reached 0 °C, 100 mL of saturated aqueous NH4Cl was then 
added slowly and the mixture stirred for 20 min before being extracted with EtOAc (3 x 
20 mL). The combined organic layers were washed with brine (100 mL), dried over 
Na2SO4, filtered and concentrated. The crude residue was purified by flash column 
chromatography (SiO2, 50% Et2O in hexanes) to give tertiary β-amidoester S3 (256 mg, 
75% yield) as a yellow oil: Rf = 0.3 (3:2 hexanes:Et2O eluent); 1H NMR (500 MHz, 
CDCl3) δ 8.48–8.41 (m, 1H), 7.47–7.41 (m, 1H), 7.34–7.25 (m, 7H), 5.93 (ddt, J = 17.2, 
10.4, 5.7 Hz, 1H), 5.35 (dq, J = 17.2, 1.5 Hz, 1H), 5.25 (dq, J = 10.5, 1.3 Hz, 1H), 4.75–
4.67 (m, 2H), 4.49 (s, 2H), 3.80 (dd, J = 8.1, 5.0 Hz, 1H), 3.68 (t, J = 6.9 Hz, 2H), 3.06 
(ddd, J = 16.4, 7.9, 4.5 Hz, 1H), 2.95 (t, J = 6.9 Hz, 2H), 2.94–2.87 (m, 1H), 2.46 (dtd, J 
= 13.0, 8.4, 4.5 Hz, 1H), 2.29 (ddt, J = 13.0, 7.9, 4.8 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 169.1, 165.0, 138.4, 134.9, 133.6, 131.6, 130.5, 128.5, 127.73, 127.65, 124.6, 
124.3, 119.1, 118.1, 116.7, 114.6, 73.2, 69.5, 66.4, 51.1, 25.02, 24.98, 20.0; IR (Neat 
Film, NaCl) 3062, 3032, 2941, 2857, 1737, 1697, 1622, 1454, 1376, 1307, 1258, 1171, 
1128, 1094, 1020, 937, 803, 746, 698 cm-1; HRMS (FAB+) m/z calc’d for C25H26NO4 
[M+H]+: 404.1856, found 404.1867.  
 
allyl 10-(2-(benzyloxy)ethyl)-7-ethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-
carboxylate (13a): To a solution of β-amidoester S3 (210 mg, 0.52 mmol, 1.0 equiv) in 
3.5 mL of CH2Cl2 were added Cs2CO3 (678 mg, 2.08 mmol, 4.0 equiv) and EtI (0.25 mL, 
3.12 mmol, 6.0 equiv) at 23 °C with stirring. After 18 h, starting material was completely 
consumed as determined by TLC analysis. Saturated aqueous NH4Cl (10 mL) was added, 
followed by extraction with EtOAc (3 x 15 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, and concentrated. Flash column chromatography 
(SiO2, 25% Et2O in hexanes) afforded quaternary β-amidoester 13a (165 mg, 73% yield) 
as a faintly yellow oil: Rf = 0.33 (7:3 hexanes:Et2O eluent); 1H NMR (400 MHz, CDCl3) 
δ 8.54–8.45 (m, 1H), 7.48–7.40 (m, 1H), 7.35–7.22 (m, 7H), 5.82 (ddt, J = 17.2, 10.4, 5.6 
Hz, 1H), 5.22 (dq, J = 17.2, 1.5 Hz, 1H), 5.16 (dq, J = 10.5, 1.3 Hz, 1H), 4.64–4.59 (m, 
2H), 4.50 (s, 2H), 3.67 (t, J = 7.0 Hz, 2H), 3.06 (dt, J = 16.8, 4.8 Hz, 1H), 2.99–2.81 (m, 
3H), 2.46 (dt, J = 13.5, 4.8 Hz, 1H), 2.23–2.06 (m, 3H), 1.03 (t, J = 7.4 Hz, 3H); 13C 
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NMR (126 MHz, CDCl3) δ 171.4, 167.8, 138.4, 135.1, 133.9, 131.5, 130.7, 128.5, 127.7, 
127.6, 124.4, 124.0, 118.8, 118.0, 116.9, 113.9, 73.2, 69.6, 66.2, 56.6, 28.9, 28.1, 24.9, 
19.1, 9.4; IR (Neat Film, NaCl) 3028, 2938, 2857, 1734, 1701, 1620, 1457, 1370, 1328, 
1310, 1225, 1189, 1098, 1020, 986, 935, 750, 697 cm-1; HRMS (ESI/APCI) m/z calc’d 
for C27H30NO4 [M+H]+: 432.2169, found 432.2177.  
 
 
 
allyl 10-bromo-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-carboxylate (S4): A 
flame-dried round bottom flask was charged with LHMDS (2.62 g, 1.69 mmol, 2.0 equiv) 
and a magnetic stirring bar in a N2-filled glove box. The flask was sealed, removed from 
the glovebox, fitted with an argon line, and suspended in a dry ice/acetone bath. THF (48 
mL) was added slowly to the flask and allowed to stir until the LHMDS had been 
completely dissolved. A solution of heteroaryl bromide 10 (2.07 g, 7.83 mmol, 1.0 equiv) 
in THF (4 mL) was added dropwise, and the reaction was allowed to stir for 30 min at –
78 °C. Allyl cyanoformate (1.04 g, 9.36 mmol, 1.2 equiv) was then added dropwise, and 
the reaction was allowed to warm slowly to 0 °C over 4 h. Once the cooling bath 
temperature reached 0 °C, saturated aqueous NH4Cl (200 mL) was then added slowly and 
the mixture stirred for 20 min before being extracted with EtOAc (3 x 250 mL). The 
combined organic layers were washed with brine (100 mL), dried over Na2SO4, filtered 
and concentrated. Flash column chromatography (SiO2, 10% EtOAc in hexanes) afforded 
tertiary β-amidoester S4 (2.67 g, 98% yield) as clear colorless oil: Rf = 0.6 (3:1 
hexanes:EtOAc eluent, orange by p-anisaldehyde stain); 1H NMR (500 MHz, CDCl3) δ 
8.46–8.41 (m, 1H), 7.50–7.44 (m, 1H), 7.39–7.33 (m, 2H), 5.93 (ddt, J = 17.1, 10.4, 5.7 
Hz, 1H), 5.35 (dq, J = 17.2, 1.5 Hz, 1H), 5.27 (dq, J = 10.4, 1.2 Hz, 1H), 4.76–4.67 (m, 
2H), 3.85 (dd, J = 7.7, 4.9 Hz, 1H), 3.08 (ddd, J = 16.9, 8.2, 4.8 Hz, 1H), 2.98 (ddd, J = 
17.0, 7.9, 4.9 Hz, 1H), 2.59–2.50 (m, 1H), 2.37 (ddt, J = 13.4, 8.2, 4.9 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 168.6, 164.5, 134.3, 134.1, 131.4, 129.0, 125.8, 125.0, 119.2, 118.7, 
116.6, 97.6, 66.6, 50.8, 24.5, 20.6; IR (Neat Film, NaCl) 3059, 2948, 2883, 1742, 1712, 
1598, 1450, 1377, 1346, 1307, 1239, 1215, 1173, 1151, 1090, 1022, 986, 924, 753 cm-1; 
HRMS (FAB+) m/z calc’d for C16H15NO3Br [M+H]+: 348.0230, found 348.0220.  
 
allyl 10-bromo-7-ethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-carboxylate 
(13b): To a solution of β-amidoester S4 (166 mg, 0.476 mmol, 1.0 equiv) in DMF (1.6 
mL) were added K2CO3 (263 mg, 1.9 mmol, 4.0 equiv) and EtI (80 µL, 0.95 mmol, 2.0 
equiv). The reaction mixture was heated to 50 °C with stirring. After 5 h, starting 
material was completely consumed as determined by TLC analysis. Saturated aqueous 
NH4Cl (5 mL) was added, followed by extraction with EtOAc (3 x 20 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated. 
Flash column chromatography (SiO2, 10% Et2O in hexanes) afforded quaternary β-
amidoester 13b (136 mg, 76% yield) as a clear colorless oil: Rf = 0.45 (17:3 
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hexanes:Et2O eluent); 1H NMR (500 MHz, CDCl3) δ 8.51–8.46 (m, 1H), 7.49–7.44 (m, 
1H), 7.39–7.32 (m, 2H), 5.84 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.25 (dq, J = 17.2, 1.5 Hz, 
1H), 5.20 (dq, J = 10.5, 1.3 Hz, 1H), 4.69–4.60 (m, 2H), 3.12 (dt, J = 17.3, 4.6 Hz, 1H), 
2.90 (ddd, J = 17.0, 11.7, 4.9 Hz, 1H), 2.53 (ddd, J = 13.6, 4.9, 4.3 Hz, 1H), 2.26–2.11 
(m, 3H), 1.06 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.9, 167.4, 134.5, 
134.4, 131.3, 129.1, 125.6, 124.8, 119.0, 118.6, 116.7, 97.0, 66.4, 56.6, 28.5, 28.1, 19.9, 
9.4; IR (Neat Film, NaCl) 3054, 2961, 2878, 1728, 1708, 1594, 1448, 1369, 1325, 1306, 
1261, 1219, 1176, 1088, 1025, 920, 798, 748 cm-1; HRMS (FAB+) m/z calc’d for 
C18H19NO3Br [M+H]+: 376.0543, found 376.0560.  
 
 
 
allyl 6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-carboxylate (S5): A flame-dried 
round bottom flask was charged with LHMDS (1.8 g, 10.8 mmol, 2.0 equiv) and a 
magnetic stirring bar in a N2-filled glove box. The flask was sealed, removed from the 
glovebox, fitted with an argon line, and suspended in a dry ice/acetone bath. THF (32 
mL) was added slowly to the flask and allowed to stir until the LHMDS had been 
completely dissolved. A solution of heteroarene 9 (1.0 g, 5.4 mmol, 1.0 equiv) in THF (4 
mL) was added dropwise, and the reaction was allowed to stir for 30 min at –78 °C. Allyl 
cyanoformate (720 mg, 6.48 mmol, 1.2 equiv) was then added dropwise, and the reaction 
mixture was allowed to warm slowly to 0 °C over 4 h. Once the cooling bath temperature 
reached 0 °C, saturated aqueous NH4Cl (200 mL) was then added slowly and the mixture 
stirred for 20 min before being extracted with EtOAc (3 x 200 mL). The combined 
organic layers were washed with brine (100 mL), dried over Na2SO4, filtered and 
concentrated. Flash column chromatography (SiO2, 15% acetone in hexanes) afforded 
tertiary β-amidoester S5 (1.32 g, 91% yield) as a faintly yellow oil which solidified to an 
off-white amorphous solid upon storage at –30 °C: Rf = 0.35 (4:1 hexanes:acetone 
eluent); 1H NMR (500 MHz, CDCl3) δ 8.45–8.42 (m, 1H), 7.48–7.44 (m, 1H), 7.32–7.24 
(m, 2H), 6.36 (td, J = 1.4, 0.7 Hz, 1H), 5.93 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.35 (dq, J 
= 17.2, 1.5 Hz, 1H), 5.26 (dq, J = 10.4, 1.2 Hz, 1H), 4.77–4.67 (m, 2H), 3.83 (dd, J = 8.0, 
5.0 Hz, 1H), 3.11 (dddd, J = 16.4, 8.1, 4.5, 1.4 Hz, 1H), 2.98 (dddd, J = 16.4, 8.5, 4.6, 1.5 
Hz, 1H), 2.55–2.46 (m, 1H), 2.38–2.29 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 169.0, 
165.2, 137.0, 135.1, 131.5, 129.9, 124.51, 124.48, 120.0, 119.1, 116.7, 105.8, 66.5, 51.1, 
25.3, 21.8; IR (Neat Film, NaCl) 3085, 3051, 2946, 2850, 1732, 1690, 1577, 1454, 1381, 
1356, 1301, 1213, 1177, 1148, 1021, 977, 932, 802, 742 cm-1; HRMS (FAB+) m/z calc’d 
for C16H16NO3 [M+H]+: 270.1130, found 270.1140. 
 
allyl 7-ethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indole-7-carboxylate (13c): To a 
solution of β-amidoester S5 (790 mg, 2.93 mmol, 1.0 equiv) in CH2Cl2 (20 mL) were 
added Cs2CO3 (3.82 g, 11.73 mmol, 4.0 equiv) and EtI (1.41 mL, 17.6 mmol, 6.0 equiv) 
at 23 °C with stirring. After 18 h, starting material was completely consumed as 
determined by TLC analysis. Saturated aqueous NH4Cl (100 mL) was added, followed by 
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extraction with EtOAc (3 x 150 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, and concentrated. Flash column chromatography (SiO2, 15% 
Et2O in hexanes) afforded quaternary β-amidoester 13c (760 mg, 87% yield) as a faintly 
yellow oil: Rf = 0.3 (17:3 hexanes:Et2O eluent); 1H NMR (500 MHz, CDCl3) δ 8.49 (ddt, 
J = 8.0, 1.3, 0.7 Hz, 1H), 7.48–7.43 (m, 1H), 7.33–7.23 (m, 2H), 6.31 (dt, J = 1.8, 0.9 Hz, 
1H), 5.84 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.24 (dq, J = 17.2, 1.5 Hz, 1H), 5.18 (dq, J = 
10.5, 1.3 Hz, 1H), 4.65 (dt, J = 5.6, 1.4 Hz, 2H), 3.07 (dtd, J = 16.8, 4.8, 1.0 Hz, 1H), 
2.98 (dddd, J = 16.7, 11.7, 4.7, 1.9 Hz, 1H), 2.47 (dt, J = 13.5, 4.6 Hz, 1H), 2.26–2.10 
(m, 3H), 1.05 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 171.3, 168.0, 137.3, 
135.3, 131.4, 130.1, 124.27, 124.25, 119.9, 118.8, 116.8, 105.2, 66.2, 56.7, 29.2, 28.2, 
20.8, 9.4; IR (Neat Film, NaCl) 3395, 3051, 2964, 2880, 1704, 1597, 1446, 1353, 1260, 
1101, 1021, 877, 798, 746 cm-1; HRMS (ESI/APCI) m/z calc’d for C18H20NO3 [M+H]+: 
298.1438, found 298.1435.  
General Procedure A: Pd-Catalyzed Allylic Alkylation 
Please note that the absolute configuration of 14a and 14c have been inferred from 
previous studies.8 The absolute configuration of 14b was assigned by conversion to (–)-
goniomitine [(–)-1]. 
 
(S)-7-allyl-10-(2-(benzyloxy)ethyl)-7-ethyl-8,9-dihydropyrido[1,2-a]indol-6(7H)-one 
(14a): An oven-dried 20 mL scintillation vial was charged with Pd2(pmdba)3 (14 mg, 
12.7 mmol, 0.1 equiv), (S)-(CF3)3-t-BuPHOX (L1, 18.8 mg, 31.8 mmol, 0.25 equiv), and 
a magnetic stirring bar in a N2-filled glove box. The vial was then charged with TBME 
(3.2 mL) and stirred at 23 °C for 30 minutes, generating a dark purple solution. To the 
preformed catalyst solution was added a solution of 13a (55 mg, 0.127 mmol, 1.0 equiv) 
in TBME (0.64 mL). The vial was sealed, removed from the glovebox, and placed in a 
preheated 60 °C heating block with stirring. Full consumption of starting material was 
achieved after 24 h, as determined by TLC analysis. The crude reaction mixture was 
stripped onto silica gel, and purified by flash column chromatography (SiO2, 5% Et2O in 
hexanes) to afford α-quaternary lactam 14a (29 mg, 59% yield) as a faintly yellow oil: Rf 
= 0.33 (17:3 hexanes:Et2O eluent); 89% ee,9 [α]D25 –29.5 (c 1.4, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 8.53–8.46 (m, 1H), 7.47–7.42 (m, 1H), 7.34–7.23 (m, 7H), 5.87–5.74 (m, 
1H), 5.14–5.10 (m, 1H), 5.09 (s, 1H), 4.50 (s, 2H), 3.69 (t, J = 7.0 Hz, 2H), 3.00–2.93 (m, 
4H), 2.62 (dd, J = 14.0, 7.0 Hz, 1H), 2.38 (dd, J = 13.8, 7.8 Hz, 1H), 2.00–1.93 (m, 2H), 
1.84 (dq, J = 14.8, 7.5 Hz, 1H), 1.72 (dq, J = 14.5, 7.4 Hz, 1H), 0.95 (t, J = 7.4 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 173.6, 138.5, 135.1, 134.4, 133.8, 130.7, 128.5, 127.71, 
127.66, 124.1, 123.7, 118.8, 117.9, 116.8, 113.2, 73.2, 69.7, 46.6, 40.0, 28.6, 28.4, 24.9, 
18.1, 8.5; IR (Neat Film, NaCl) 3066, 3032, 2930, 2856, 1694, 1619, 1455, 1366, 1309, 
N
O O
O
Et
Pd2(pmdba)3 (10 mol %)L1  (25 mol %)
TBME, 60 °C
N
O Et P N
O
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(4-CF3-C6H4)2
OBn OBn
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1260, 1189, 1100, 1073, 1020, 916, 801, 750, 696 cm-1; HRMS (FAB+) m/z calc’d for 
C26H30NO2 [M+H]+: 388.2271, found 388.2269. 
 
methyl (S,E)-4-(10-(2-(benzyloxy)ethyl)-7-ethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-
a]indol-7-yl)but-2-enoate (S6): To a solution of terminal olefin 14a (11 mg, 28 µmol, 
1.0 equiv) and methyl acrylate (25 mg, 280 µmol, 10 equiv) in CH2Cl2 (0.6 mL) was 
added Grubb’s second generation catalyst (1.2 mg, 1.4 µmol, 0.05 equiv) at 23 °C. The 
reaction was sealed and placed in a preheated 40 °C heating block with stirring. After 3 h, 
complete consumption of starting material was observed by TLC analysis. Flash column 
chromatography (SiO2, 35% Et2O in hexanes) afforded α,β-unsaturated ester S6 (3.8 mg, 
30% yield) as a clear colorless oil: Rf = 0.2 (7:3 hexanes:Et2O eluent); 89% ee, [α]D25 –
64.4 (c 0.11, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.50–8.45 (m, 1H), 7.47–7.42 (m, 
1H), 7.34–7.22 (m, 7H), 6.95 (ddd, J = 15.5, 8.2, 7.1 Hz, 1H), 5.94–5.89 (m, 1H), 4.50 (s, 
2H), 3.71 (s, 3H), 3.69 (t, J = 7.2 Hz, 2H), 3.00–2.92 (m, 4H), 2.79 (ddd, J = 14.2, 7.1, 
1.6 Hz, 1H), 2.52 (ddd, J = 14.2, 8.3, 1.3 Hz, 1H), 1.96 (dd, J = 7.3, 6.0 Hz, 2H), 1.78 
(qd, J = 7.4, 4.6 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 172.8, 
166.6, 144.6, 138.4, 135.0, 133.9, 130.7, 128.5, 127.73, 127.67, 124.6, 124.3, 123.9, 
118.0, 116.8, 113.7, 73.2, 69.6, 51.7, 46.7, 38.0, 29.0, 28.4, 24.9, 18.1, 8.5; IR (Neat 
Film, NaCl) 3028, 2923, 2854, 1722, 1693, 1620, 1455, 1434, 1371, 1312, 1271, 1187, 
1101, 1074, 1021, 751, 697 cm-1; HRMS (FAB+) m/z calc’d for C28H31NO4 [M]+: 
445.2248, found 445.2246; SFC conditions: 8% i-PrOH, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 40.93, minor = 44.73. 
 
(S)-7-allyl-10-bromo-7-ethyl-8,9-dihydropyrido[1,2-a]indol-6(7H)-one (14b): The 
reaction was conducted according to general procedure A. α-Quaternary β-amidoester 
13b (386 mg, 1.02 mmol, 1.0 equiv); Pd2(pmdba)3 (56 mg, 51 µmol, 0.05 equiv); (S)-
(CF3)3-t-BuPHOX (L1, 76 mg, 0.128 mmol, 0.125 equiv); TBME (31 mL). The reaction 
mixture was stirred for 8 h at 60 °C. Flash column chromatography (SiO2, 40% CH2Cl2 in 
hexanes) afforded α-quaternary lactam 14b (274 mg, 83% yield) as a clear colorless oil: 
Rf = 0.33 (2:1 hexanes:CH2Cl2 eluent); 96% ee, [α]D25 –36.0 (c 1.26, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 8.50–8.47 (m, 1H), 7.49–7.45 (m, 1H), 7.37–7.31 (m, 2H), 5.81 
N
O Et
OBn
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O Et
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CO2Me
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(dddd, J = 16.6, 10.5, 7.7, 6.9 Hz, 1H), 5.16–5.14 (m, 1H), 5.12 (t, J = 1.2 Hz, 1H), 3.08–
2.94 (m, 2H), 2.63 (ddt, J = 14.0, 7.0, 1.3 Hz, 1H), 2.40 (ddt, J = 14.0, 7.8, 1.1 Hz, 1H), 
2.10–1.99 (m, 2H), 1.85 (dq, J = 14.0, 7.5 Hz, 1H), 1.81–1.69 (m, 1H), 0.97 (t, J = 7.5 
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 173.1, 135.0, 134.3, 133.4, 129.2, 125.3, 124.4, 
119.1, 118.4, 116.7, 96.3, 46.7, 39.8, 28.4, 28.2, 18.9, 8.5; IR (Neat Film, NaCl) 3075, 
2971, 2939, 1704, 1639, 1594, 1449, 1367, 1348, 1307, 1179, 1151, 1057, 1025, 922, 751 
cm-1; HRMS (FAB+) m/z calc’d for C17H18NOBr [M]+: 331.0566, found 331.0566; SFC 
conditions: 2% MeOH, 3 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major 
= 11.87, minor = 11.11. 
 
(S)-7-allyl-7-ethyl-8,9-dihydropyrido[1,2-a]indol-6(7H)-one (14c): The reaction was 
conducted according to general procedure A. α-Quaternary β-amidoester 13c (730 mg, 
2.45 mmol, 1.0 equiv); Pd2(pmdba)3 (134 mg, 0.12 mmol, 0.05 equiv); (S)-(CF3)3-t-
BuPHOX (L1, 181 mg, 0.31 mmol, 0.125 equiv); TBME (74 mL). The reaction mixture 
was stirred for 24 h. Flash column chromatography (SiO2, 5% Et2O in hexanes) afforded 
α-quaternary lactam 14c (410 mg, 71% yield) as a clear colorless oil: Rf = 0.6 (17:3 
hexanes:Et2O eluent); 94% ee, [α]D25 –69.7 (c 2.09, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 8.52–8.45 (m, 1H), 7.48–7.43 (m, 1H), 7.31–7.20 (m, 2H), 6.29 (td, J = 1.5, 0.8 Hz, 
1H), 5.82 (dddd, J = 17.0, 10.2, 7.7, 6.9 Hz, 1H), 5.16–5.11 (m, 1H), 5.14–5.07 (m, 1H), 
3.04 (tt, J = 6.3, 1.4 Hz, 2H), 2.64 (ddt, J = 14.0, 6.9, 1.3 Hz, 1H), 2.41 (ddt, J = 13.9, 
7.8, 1.1 Hz, 1H), 2.08–1.95 (m, 2H), 1.87 (dq, J = 13.9, 7.5 Hz, 1H), 1.83–1.68 (m, 1H), 
0.97 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 173.8, 137.9, 135.3, 133.7, 
130.2, 124.0, 123.9, 119.8, 118.8, 116.7, 104.6, 46.7, 40.1, 28.9, 28.6, 19.8, 8.5; IR (Neat 
Film, NaCl) 3073, 2968, 2940, 2877, 1691, 1595, 1573, 1450, 1354, 1299, 1181, 1049, 
1004, 911, 795, 743 cm-1; HRMS (ESI/APCI) m/z calc’d for C17H20NO [M+H]+: 
254.1539, found 254.1534; SFC conditions: 2% MeOH, 3 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 11.08, minor = 10.06. 
 
tert-butyl (S)-2-(7-allyl-7-ethyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-
yl)acetate (16): To an oven-dried 20 mL scintillation vial was charged heteroaryl 
bromide 14b (188 mg, 0.565 mmol, 1.0 equiv), PdCl2(AtaPhos)2 (12 mg, 17 mmol, 0.03 
equiv), THF (4.2 mL), and a magnetic stirring bar in a N2-filled glovebox. A 
N
O Et
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N
O Et
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O
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commercially available (from Rieke Metals) solution of Reformatsky reagent 15 in Et2O 
(1.47 mL, 0.5 M, 0.735 mmol, 1.3 equiv) was added dropwise. The reaction was sealed 
and placed in a preheated 65 °C heating block with stirring. After 3 h, full consumption 
of starting material was observed by TLC analysis. The solution was cooled to 23 °C and 
MeOH (ca. 1 mL) was added to quench any excess Reformatsky reagent. The crude 
reaction mixture was stripped onto silica gel and purified by flash column 
chromatography (SiO2, 8% Et2O in hexanes) to afford cross-coupled product 13 (204 mg, 
98% yield) as a clear colorless oil: Rf = 0.25 (9:1 hexanes:Et2O eluent); [α]D25 –39.8 (c 
0.35, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.49–8.47 (m, 1H), 7.50–7.47 (m, 1H), 
7.31–7.25 (m, 2H), 5.82 (dddd, J = 17.1, 10.2, 7.7, 6.9 Hz, 1H), 5.13 (ddt, J = 9.5, 2.0, 
1.2 Hz, 1H), 5.10 (q, J = 1.2 Hz, 1H), 3.54 (s, 2H), 3.07–2.95 (m, 2H), 2.63 (ddt, J = 
14.0, 7.0, 1.3 Hz, 1H), 2.41 (ddt, J = 14.0, 7.7, 1.1 Hz, 1H), 2.07–1.96 (m, 2H), 1.91–1.80 
(m, 1H), 1.79–1.70 (m, 1H), 1.43 (s, 9H), 0.96 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 173.6, 170.2, 135.03, 134.96, 133.7, 130.3, 124.3, 123.8, 118.8, 118.2, 116.7, 
109.9, 81.3, 46.6, 39.9, 31.6, 28.5, 28.4, 28.2, 18.1, 8.5; IR (Neat Film, NaCl) 3073, 
2972, 2933, 1729, 1698, 1618, 1456, 1366, 1311, 1259, 1141, 1075, 1022, 917, 802, 752 
cm-1; HRMS (ESI/APCI) m/z calc’d for C23H30NO3 [M+H]+: 368.2220, found 368.2210. 
 
 
(–)-goniomitine (1): An oven-dried scintillation vial was charged with α-quaternary 
lactam 16 (137 mg, 0.37 mmol, 1.0 equiv), THF (1.5 mL), and a magnetic stirring bar in 
a N2-filled glovebox. To this solution was added bis(cyclopentadienyl) zirconium 
chloride hydride (115 mg, 0.445 mmol, 1.2 equiv), and the mixture was stirred at 23 °C 
until a yellow solution was observed (ca. 45 min). An additional portion of 
bis(cyclopentadienyl) zirconium chloride hydride (29 mg, 0.11 mmol, 0.3 equiv) was 
added and the reaction mixture was stirred for an additional 30 min. Hydroxylamine-O-
sulfonic acid (71 mg, 0.63 mmol, 1.7 equiv) was added, the vial was sealed and removed 
from the glovebox, and stirring was resumed at 23 °C in a fume hood for an additional 30 
min. The crude reaction mixture was loaded directly onto a short plug of silica gel and 
eluted with 10% MeOH in CH2Cl2 to deliver primary amine 17 (98 mg, Rf = 0.2, 9:1 
CH2Cl2:MeOH eluent) as an orange foam. Semi-crude primary amine 17 was 
immediately dissolved in THF (5.1 mL) and cooled to 0 °C. A solution of LiAlH4 (1.02 
mL, 1 M in THF, 4.0 equiv) was added dropwise, and the reaction was stirred at 0 °C for 
1 h. At this point, the cooling bath was removed and the reaction was stirred for an 
additional 6 h. The reaction was cooled to 0 °C and quenched by the careful addition of 
H2O (5 mL) and AcOH (15 mL) and stirred for 6 hours. The solution was basified with 
2N NaOH until pH > 12, and then was extracted with EtOAc (3 x 100 mL), dried over 
Na2SO4, filtered and concentrated. Flash column chromatography (SiO2, 3% MeOH in 
CH2Cl2 eluent) afforded (–)-goniomitine (1) (33 mg, 30% yield over two steps) as a 
N
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faintly yellow oil: Rf = 0.45 (9:1 CH2Cl2:MeOH eluent); [α]D25 –67.1 (c 0.085, CHCl3 
(passed through basic alumina)); 1H NMR (500 MHz, CDCl3 (passed through basic 
alumina)) δ 7.51 (dt, J = 7.7, 1.0 Hz, 1H), 7.29 (dt, J = 8.2, 1.0 Hz, 1H), 7.14 (ddd, J = 
8.1, 7.0, 1.2 Hz, 1H), 7.08 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 4.79 (s, 1H), 3.83 (t, J = 6.5 
Hz, 2H), 3.08–3.00 (m, 2H), 2.98–2.90 (m, 2H), 2.88–2.76 (m, 2H), 2.52 (td, J = 12.9, 
6.6 Hz, 1H), 1.93–1.87 (m, 1H), 1.79–1.66 (m, 3H), 1.6 (dq, J = 15, 7.6 Hz, 1H), 1.55–
1.45 (m, 3H), 1.21 (dq, J = 14.7, 7.3 Hz, 1H), 0.89 (t, J = 7.6 Hz, 3H). (500 MHz, CDCl3 
(passed through basic alumina)) δ 7.51 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.15 
(ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.08 (ddd, J = 7.9, 7.1, 1.1 Hz, 1H), 4.80 (s, 1H), 3.83 (td, 
J = 6.4, 1.3 Hz, 2H), 3.11 (ddd, J = 17.3, 6.7, 1.5 Hz, 2H), 2.93 (td, J = 6.5, 2.2 Hz, 2H), 
2.86–2.72 (m, 2H), 2.51 (td, J = 12.9, 6.6 Hz, 1H), 1.91–1.85 (m, 1H), 1.75–1.65 (m, 
1H), 1.57 (dt, J = 15.0, 7.5 Hz, 1H), 1.53–1.44 (m, 3H), 1.20 (dq, J = 14.7, 7.7 Hz, 1H), 
0.87 (t, J = 7.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 135.5, 132.8, 129.2, 120.7, 
119.7, 118.2, 108.4, 106.1, 71.7, 62.7, 45.8, 35.2, 34.2, 28.8, 27.8, 21.8, 21.7, 18.7, 7.2; 
IR (Neat Film, NaCl) 3288 (br), 3051, 2934, 2877, 2241, 1679, 1611, 1462, 1416, 1357, 
1309, 1203, 1188, 1108, 1044, 1013, 908, 867, 737 cm-1; HRMS (ESI/APCI) m/z calc’d 
for C19H27N2O [M+H]+: 299.2118, found 299.2121. 
 
 
 
(R)-3-(2-(1H-indol-2-yl)ethyl)-3-ethylpiperidin-2-one (18): An oven-dried 1-dram vial 
was charged with α-quaternary lactam 14c (40 mg, 0.16 mmol, 1.0 equiv), THF (0.8 
mL), and a magnetic stirring bar in a N2-filled glovebox. To this solution was added 
bis(cyclopentadienyl) zirconium chloride hydride (49 mg, 0.19 mmol, 1.2 equiv), and the 
mixture was stirred at 23 °C until a light yellow solution was observed (ca. 30 min). 
Hydroxylamine-O-sulfonic acid (29 mg, 0.25 mmol, 1.6 equiv) was added, the vial was 
sealed and removed from the glovebox, and stirring was resumed at 23 °C in a fume hood 
for an additional 30 min. The crude reaction mixture was loaded directly onto a short 
plug of silica gel and eluted with 10% MeOH in CH2Cl2 to deliver the intermediate 
primary amine (Rf = 0.2, 9:1 CH2Cl2:MeOH eluent). The semi-crude primary amine was 
immediately dissolved in MeOH (5.2 mL), then K2CO3 (65 mg, 0.47 mmol, 3.0 equiv) 
was added. The reaction was stirred at 23 °C for 1 h, at which point complete 
consumption of starting material was determined by TLC analysis. Flash column 
chromatography (SiO2, 40% acetone in hexanes) afforded free Ν–H lactam 18 (28 mg, 
66% yield over two steps) as a white amorphous solid: Rf = 0.3 (3:2 hexanes:acetone 
eluent); [α]D25 –32.7 (c 0.41, CH3OH); 1H NMR (500 MHz, CDCl3) δ 8.43 (br s, 1H), 
7.50 (ddt, J = 7.7, 1.4, 0.8 Hz, 1H), 7.29 (dq, J = 8.0, 1.0 Hz, 1H), 7.09 (ddd, J = 8.1, 7.1, 
1.3 Hz, 1H), 7.07–7.02 (m, 1H), 6.21 (dd, J = 2.0, 0.9 Hz, 1H), 5.83 (br s, 1H), 3.32 (td, J 
= 5.7, 2.2 Hz, 2H), 2.90–2.82 (m, 1H), 2.69 (dddd, J = 14.7, 11.1, 4.6, 1.0 Hz, 1H), 2.13 
(ddd, J = 13.6, 11.2, 4.5 Hz, 1H), 1.90–1.75 (m, 6H), 1.67–1.60 (m, 1H), 0.91 (t, J = 7.5 
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 177.2, 140.0, 136.2, 128.8, 121.0, 119.8, 119.5, 
110.6, 99.3, 45.3, 42.9, 37.8, 31.3, 29.2, 23.9, 19.8, 8.6; IR (Neat Film, NaCl) 3285, 
N
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3252, 2971, 2952, 2868, 1643, 1588, 1486, 1456, 1421, 1351, 1328, 1287, 1216, 1104, 
1010, 795, 735 cm-1; HRMS (ESI/APCI) m/z calc’d for C17H23N2O [M+H]+: 271.1805, 
found 271.1813. 
 
Determination of Enantiomeric Excess (Table S1) 
 
  
 
Comparison of Synthetic Material to Published Data 
 
The optical rotation of our synthetic (–)-goniomitine, [α]D25 –67.1 (c 0.085, CHCl3 
(passed through basic alumina)), differs from values previously reported in the literature: 
[α]D25 –80 (c 0.9, CHCl3),10 [α]D25 –87.1 (c 0.42, CHCl3),11 [α]D25 –78.1 (c 0.14, CHCl3),12 
[α]D25 –80 (c 0.46, CHCl3).13 We have also noted that some 13CNMR resonances of the 
natural product vary depending on the CDCl3 used to make the sample (vide supra). 
Since we obtained SFC traces of both rac- and (–)-14b, and since the quaternary center is 
not susceptible to racemization, we do not believe that this discrepancy indicates erosion 
of enantiopurity. 
 
 
 
 
 
 
 
entry product assay conditions ee (%)
1
SFC: 8% IPA, 2.5 mL/min
Chiralpak AD-H, λ = 210 nm
tR (min): major 40.93, minor 44.73
89
2
SFC: 2% MeOH, 3 mL/min
Chiralpak AD-H, λ = 210 nm
tR (min): major 11.87, minor 11.11
96
3
SFC: 2% MeOH, 3 mL/min
Chiralpak AD-H, λ = 210 nm
tR (min): major 11.08, minor 10.06
94
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Comparison of Synthetic and Natural (–)-Goniomitine (Table S2) 
 
Synthetic (–)-goniomitine 
(CDCl3 directly from bottle) 
Synthetic (–)-goniomitine 
(CDCl3 filtered through basic alumina) 
Natural (–)-goniomitine10 
1H NMR (500 MHz, CDCl3) 1H NMR (500 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) 
4.80 (s, 1H) 4.79 (s, 1H) 4.86 (s, 1H) 
3.83 (t, J = 6.4, 2H) 3.83 (t, J = 6.5, 2H) 3.81 (t, 2H) 
2.93 (td, J = 6.5, 2.2 Hz, 2H) 2.94 (td, J = 6.6, 3.3 Hz, 2H) 3.0 (t, 2H) 
1.57 (dt, J = 15.0, 7.5 Hz, 1H) 1.57 (dt, J = 15.0, 7.5 Hz, 1H) 1.56 (m, J = 7 Hz, 1H) 
1.20 (dq, J = 14.7, 7.7 Hz, 1H) 1.21 (dq, J = 14.7, 7.3 Hz, 1H) 1.20 (m, J = 7 Hz, 1H) 
0.87 (t, J = 7.6 Hz, 3H) 0.89 (t, J = 7.6 Hz, 3H) 0.86 (t, J = 7 Hz, 3H) 
13C NMR (126 MHz, CDCl3) 13C NMR (126 MHz, CDCl3) 13C NMR (CDCl3) 
135.4 135.5 135.4 
132.6 132.8 132.6 
129.3 129.2 129.3 
120.9 120.7 120.8 
120.1 119.7 119.9 
118.2 118.2 118.1 
108.7 108.4 108.7 
107.4 106.1 106.8 
70.6 71.7 71.1 
62.5 62.7 62.6 
44.9 45.8 45.4 
35.3 35.2 35.3 
33.6 34.2 33.8 
28.7 28.8 28.7 
27.7 27.8 27.8 
21.7 21.8 21.8 
20.3 21.7 20.8 
18.5 18.7 18.5 
7.2 7.2 7.3 
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1HNMR spectrum of our synthetic (–)-goniomitine (500 MHz, CDCl3) 
 
 
 
 
 
 
 
 
 
1HNMR spectrum of (–)-goniomitine synthesized by Jia et al (400 MHz, CDCl3)13 
 
 
 
 
 
 
 
 
 
 
 
13CNMR spectrum of our synthetic (–)-goniomitine (126 MHz, CDCl3) 
 
 
 
 
 
 
 
 
 
 
 
13CNMR spectrum of (–)-goniomitine synthesized by Jia et al (100 MHz, CDCl3)13 
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 13C NMR (126 MHz, CDCl3) of compound S2. 
 
Infrared spectrum (Thin Film, NaCl) of compound S2. 
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 13C NMR (126 MHz, CDCl3) of compound 10. 
 
Infrared spectrum (Thin Film, NaCl) of compound 10. 
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 13C NMR (126 MHz, CDCl3) of compound S3. 
 
Infrared spectrum (Thin Film, NaCl) of compound S3. 
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 13C NMR (101 MHz, CDCl3) of compound 13a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 13a. 
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 13C NMR (126 MHz, CDCl3) of compound S4. 
 
Infrared spectrum (Thin Film, NaCl) of compound S4. 
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 13C NMR (126 MHz, CDCl3) of compound 13b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 13b. 
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 13C NMR (126 MHz, CDCl3) of compound S5. 
 
Infrared spectrum (Thin Film, NaCl) of compound S5. 
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 13C NMR (126 MHz, CDCl3) of compound 13c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 13c. 
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 13C NMR (126 MHz, CDCl3) of compound 14a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 14a. 
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 13C NMR (101 MHz, CDCl3) of compound S6. 
 
Infrared spectrum (Thin Film, NaCl) of compound S6. 
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 13C NMR (126 MHz, CDCl3) of compound 14b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 14b. 
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 13C NMR (101 MHz, CDCl3) of compound 14c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 14c. 
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 13C NMR (126 MHz, CDCl3) of compound 16. 
 
Infrared spectrum (Thin Film, NaCl) of compound 16. 
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 13C NMR (126 MHz, CDCl3) of (–)-goniomitine (1). 
 
Infrared spectrum (Thin Film, NaCl) of (–)-goniomitine (1). 
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 13C NMR (126 MHz, CDCl3) of compound 18. 
 
Infrared spectrum (Thin Film, NaCl) of compound 18. 
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